Co-nanoencapsulated meloxicam and curcumin improves cognitive impairment induced by amyloid-beta through modulation of cyclooxygenase-2 in mice

Alzheimer’s disease (AD) is a progressive brain disorder and complex mechanisms are involved in the physiopathology of AD. However, there is data suggesting that inflammation plays a role in its development and progression. Indeed, some non-steroidal anti-inflammatory drugs, such as meloxicam, which...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Maria Eduarda Ziani Gutierrez, Anne Suély Pinto Savall, Edina da Luz Abreu, Kelly Ayumi Nakama, Renata Bem Dos Santos, Marina Costa Monteiro Guedes, Daiana Silva Ávila, Cristiane Luchese, Sandra Elisa Haas, Caroline Brandão Quines, Simone Pinton
Format:	Artigo
Sprog:	Inglês
Udgivet:	Wolters Kluwer Medknow Publications 2021-01-01
Serier:	Neural Regeneration Research
Fag:	alzheimer’s disease; curcumin; cyclooxygenase-2; lipid core nanocapsules; meloxicam; memory; rats; inflammation
Online adgang:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=4;spage=783;epage=789;aulast=Gutierrez
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!